Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Arcturus Therapeutics Holdings Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 30, 2021 / 04:00PM GMT
Release Date Price: $47.78 (+2.20%)
Brian Cheng
Cantor Fitzgerald - Analyst

Good afternoon, everyone. Thank you for joining us today at our annual Global Healthcare conference. I'm Brian Cheng. I'm the Senior Biotech Analyst here at Cantor. It is my pleasure to introduce you to the next management team from Arcturus. Joining us is their CEO, Joe Payne. Joe, welcome, and thanks for joining us today.

Joe Payne
Arcturus Therapeutics Holdings Inc. - President & CEO

Hey, Brian, it's good to be with you. Thanks for the opportunity. Appreciate it.

Brian Cheng
Cantor Fitzgerald - Analyst

Thanks. Yes, thank you. Yes, good to see you. So let's start off with a presentation from Joe, and then we'll wrap up with a short Q&A at the end. Joe, the floor is yours.

Joe Payne
Arcturus Therapeutics Holdings Inc. - President & CEO

Great. Thanks, Brian. Arcturus Therapeutics, for those that are not aware, we are a clinical-stage messenger RNA vaccines and medicines company. A few years ago, I used to, as part

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot